1
Total investments
1
Early stage
0
Mid stage
0
Late stage
—
Years active
Portfolio
1 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor
We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression.
We want to transform the patient experience in mental health care.
Experience · 1 entries
All (1)
Investments (1)
Investor
We are Compass Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression.
We want to transform the patient experience in mental health care.